Hormone receptor positive metastatic breast cancer
Clinical trials for Hormone receptor positive metastatic breast cancer explained in plain language.
Never miss a new study
Get alerted when new Hormone receptor positive metastatic breast cancer trials appear
Sign up with your email to follow new studies for Hormone receptor positive metastatic breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a targeted drug boost hormone therapy against breast cancer?
Disease control CompletedThis trial is testing whether adding an experimental drug called BYL719 to standard hormone therapy (letrozole) can better fight hormone receptor-positive metastatic breast cancer in post-menopausal women. BYL719 targets a protein that helps cancer cells grow, while letrozole blo…
Matched conditions: HORMONE RECEPTOR POSITIVE METASTATIC BREAST CANCER
Phase 1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New drug combo shows promise in resistant breast cancer
Disease control CompletedThis phase 2 study tested whether adding ganetespib, an experimental drug that blocks a protein called HSP90, to the standard hormone therapy fulvestrant could help people with hormone receptor-positive metastatic breast cancer that has stopped responding to hormone treatment. Th…
Matched conditions: HORMONE RECEPTOR POSITIVE METASTATIC BREAST CANCER
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC